nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—CYP2A6—lung cancer	0.228	1	CbGaD
Valproic Acid—UGT1A9—Irinotecan—lung cancer	0.0352	0.0906	CbGbCtD
Valproic Acid—SLC16A1—Methotrexate—lung cancer	0.0324	0.0835	CbGbCtD
Valproic Acid—SLC22A7—Docetaxel—lung cancer	0.0221	0.0569	CbGbCtD
Valproic Acid—CYP3A5—Gefitinib—lung cancer	0.0164	0.0423	CbGbCtD
Valproic Acid—SLC22A7—Methotrexate—lung cancer	0.0159	0.0411	CbGbCtD
Valproic Acid—CYP3A5—Teniposide—lung cancer	0.0159	0.041	CbGbCtD
Valproic Acid—CYP2C19—Gefitinib—lung cancer	0.0132	0.0341	CbGbCtD
Valproic Acid—CYP2C19—Teniposide—lung cancer	0.0128	0.0331	CbGbCtD
Valproic Acid—PTGS1—Etoposide—lung cancer	0.0117	0.0301	CbGbCtD
Valproic Acid—CYP2B6—Irinotecan—lung cancer	0.0111	0.0287	CbGbCtD
Valproic Acid—CYP2C9—Gefitinib—lung cancer	0.011	0.0284	CbGbCtD
Valproic Acid—CYP2C9—Teniposide—lung cancer	0.0107	0.0275	CbGbCtD
Valproic Acid—CYP3A5—Crizotinib—lung cancer	0.0101	0.0259	CbGbCtD
Valproic Acid—SLC22A8—Methotrexate—lung cancer	0.00973	0.0251	CbGbCtD
Valproic Acid—CYP3A5—Erlotinib—lung cancer	0.00971	0.025	CbGbCtD
Valproic Acid—CYP2C8—Erlotinib—lung cancer	0.00933	0.024	CbGbCtD
Valproic Acid—CYP2B6—Cisplatin—lung cancer	0.00907	0.0234	CbGbCtD
Valproic Acid—CYP3A5—Paclitaxel—lung cancer	0.00889	0.0229	CbGbCtD
Valproic Acid—CYP3A5—Irinotecan—lung cancer	0.00877	0.0226	CbGbCtD
Valproic Acid—CYP2C8—Paclitaxel—lung cancer	0.00854	0.022	CbGbCtD
Valproic Acid—CYP1A2—Erlotinib—lung cancer	0.00723	0.0186	CbGbCtD
Valproic Acid—CYP3A5—Etoposide—lung cancer	0.00702	0.0181	CbGbCtD
Valproic Acid—CYP3A4—Topotecan—lung cancer	0.007	0.018	CbGbCtD
Valproic Acid—SLC22A6—Methotrexate—lung cancer	0.00678	0.0175	CbGbCtD
Valproic Acid—CYP2C8—Etoposide—lung cancer	0.00675	0.0174	CbGbCtD
Valproic Acid—CYP3A5—Docetaxel—lung cancer	0.00643	0.0166	CbGbCtD
Valproic Acid—CYP3A4—Gefitinib—lung cancer	0.0064	0.0165	CbGbCtD
Valproic Acid—CYP3A4—Teniposide—lung cancer	0.00621	0.016	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—lung cancer	0.00608	0.0157	CbGbCtD
Valproic Acid—CYP2C9—Paclitaxel—lung cancer	0.00596	0.0154	CbGbCtD
Valproic Acid—CYP1A2—Etoposide—lung cancer	0.00523	0.0135	CbGbCtD
Valproic Acid—CYP3A4—Vinorelbine—lung cancer	0.00493	0.0127	CbGbCtD
Valproic Acid—CYP2C9—Cisplatin—lung cancer	0.00479	0.0123	CbGbCtD
Valproic Acid—CYP3A4—Crizotinib—lung cancer	0.00392	0.0101	CbGbCtD
Valproic Acid—CYP3A4—Erlotinib—lung cancer	0.00379	0.00975	CbGbCtD
Valproic Acid—CYP3A4—Paclitaxel—lung cancer	0.00347	0.00893	CbGbCtD
Valproic Acid—CYP3A4—Irinotecan—lung cancer	0.00342	0.00881	CbGbCtD
Valproic Acid—CYP3A4—Vinblastine—lung cancer	0.00304	0.00783	CbGbCtD
Valproic Acid—OGDH—mammary gland—lung cancer	0.00297	0.0543	CbGeAlD
Valproic Acid—CYP3A4—Etoposide—lung cancer	0.00274	0.00705	CbGbCtD
Valproic Acid—UGT2B15—mammary gland—lung cancer	0.00268	0.049	CbGeAlD
Valproic Acid—CYP3A4—Docetaxel—lung cancer	0.00251	0.00645	CbGbCtD
Valproic Acid—ACADSB—mammary gland—lung cancer	0.00236	0.0431	CbGeAlD
Valproic Acid—OGDH—respiratory system—lung cancer	0.00198	0.0362	CbGeAlD
Valproic Acid—CYP3A4—Doxorubicin—lung cancer	0.00187	0.00481	CbGbCtD
Valproic Acid—ABAT—mammary gland—lung cancer	0.00178	0.0325	CbGeAlD
Valproic Acid—HDAC9—respiratory system—lung cancer	0.00174	0.0319	CbGeAlD
Valproic Acid—OGDH—bronchus—lung cancer	0.00163	0.0298	CbGeAlD
Valproic Acid—UGT1A4—respiratory system—lung cancer	0.00161	0.0295	CbGeAlD
Valproic Acid—OGDH—trachea—lung cancer	0.00146	0.0267	CbGeAlD
Valproic Acid—HDAC9—bronchus—lung cancer	0.00144	0.0263	CbGeAlD
Valproic Acid—OGDH—cardiac atrium—lung cancer	0.00137	0.0251	CbGeAlD
Valproic Acid—HDAC2—mammary gland—lung cancer	0.00134	0.0245	CbGeAlD
Valproic Acid—ACADSB—bronchus—lung cancer	0.00129	0.0237	CbGeAlD
Valproic Acid—HDAC9—trachea—lung cancer	0.00129	0.0236	CbGeAlD
Valproic Acid—ACADSB—trachea—lung cancer	0.00116	0.0212	CbGeAlD
Valproic Acid—OGDH—bone marrow—lung cancer	0.00116	0.0212	CbGeAlD
Valproic Acid—ALDH5A1—bronchus—lung cancer	0.00114	0.0208	CbGeAlD
Valproic Acid—ACADSB—cardiac atrium—lung cancer	0.00109	0.02	CbGeAlD
Valproic Acid—OGDH—lung—lung cancer	0.00105	0.0192	CbGeAlD
Valproic Acid—HDAC9—bone marrow—lung cancer	0.00102	0.0187	CbGeAlD
Valproic Acid—ALDH5A1—Vinblastine—Vinorelbine—lung cancer	0.000989	0.295	CbGdCrCtD
Valproic Acid—CYP2C18—bronchus—lung cancer	0.000972	0.0178	CbGeAlD
Valproic Acid—ALDH5A1—cardiac atrium—lung cancer	0.000961	0.0176	CbGeAlD
Valproic Acid—HDAC9—lung—lung cancer	0.000926	0.0169	CbGeAlD
Valproic Acid—ACADSB—bone marrow—lung cancer	0.000921	0.0169	CbGeAlD
Valproic Acid—HDAC2—respiratory system—lung cancer	0.000892	0.0163	CbGeAlD
Valproic Acid—ACADSB—lung—lung cancer	0.000835	0.0153	CbGeAlD
Valproic Acid—ALDH5A1—bone marrow—lung cancer	0.000811	0.0148	CbGeAlD
Valproic Acid—HDAC2—epithelium—lung cancer	0.000745	0.0136	CbGeAlD
Valproic Acid—ALDH5A1—lung—lung cancer	0.000735	0.0134	CbGeAlD
Valproic Acid—HDAC2—bronchus—lung cancer	0.000734	0.0134	CbGeAlD
Valproic Acid—OGDH—lymph node—lung cancer	0.000719	0.0131	CbGeAlD
Valproic Acid—SLC22A5—mammary gland—lung cancer	0.000679	0.0124	CbGeAlD
Valproic Acid—HDAC2—Topotecan—Irinotecan—lung cancer	0.000672	0.2	CbGdCrCtD
Valproic Acid—SLC16A1—epithelium—lung cancer	0.000662	0.0121	CbGeAlD
Valproic Acid—CYP2C8—mammary gland—lung cancer	0.000658	0.012	CbGeAlD
Valproic Acid—HDAC9—lymph node—lung cancer	0.000634	0.0116	CbGeAlD
Valproic Acid—ABAT—lung—lung cancer	0.000629	0.0115	CbGeAlD
Valproic Acid—CYP2C9—mammary gland—lung cancer	0.000584	0.0107	CbGeAlD
Valproic Acid—ACADSB—lymph node—lung cancer	0.000571	0.0104	CbGeAlD
Valproic Acid—SLC16A1—cardiac atrium—lung cancer	0.00055	0.0101	CbGeAlD
Valproic Acid—HDAC2—bone marrow—lung cancer	0.000523	0.00956	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—lung cancer	0.000503	0.00919	CbGeAlD
Valproic Acid—HDAC2—Methotrexate—Pemetrexed—lung cancer	0.000479	0.143	CbGdCrCtD
Valproic Acid—HDAC2—lung—lung cancer	0.000474	0.00866	CbGeAlD
Valproic Acid—HDAC2—Afatinib—Gefitinib—lung cancer	0.000462	0.137	CbGdCrCtD
Valproic Acid—SLC22A5—respiratory system—lung cancer	0.000453	0.00828	CbGeAlD
Valproic Acid—HDAC2—Gefitinib—Erlotinib—lung cancer	0.000453	0.135	CbGdCrCtD
Valproic Acid—ABAT—lymph node—lung cancer	0.00043	0.00786	CbGeAlD
Valproic Acid—SLC16A1—lung—lung cancer	0.000421	0.0077	CbGeAlD
Valproic Acid—CYP2A6—lung—lung cancer	0.000415	0.00758	CbGeAlD
Valproic Acid—CYP1A2—respiratory system—lung cancer	0.00041	0.0075	CbGeAlD
Valproic Acid—CYP3A5—respiratory system—lung cancer	0.000396	0.00724	CbGeAlD
Valproic Acid—CYP2B6—respiratory system—lung cancer	0.000393	0.00719	CbGeAlD
Valproic Acid—SLC22A5—bronchus—lung cancer	0.000373	0.00682	CbGeAlD
Valproic Acid—PTGS1—respiratory system—lung cancer	0.000355	0.0065	CbGeAlD
Valproic Acid—SLC22A5—trachea—lung cancer	0.000335	0.00612	CbGeAlD
Valproic Acid—HDAC2—lymph node—lung cancer	0.000324	0.00592	CbGeAlD
Valproic Acid—CYP2B6—bronchus—lung cancer	0.000324	0.00592	CbGeAlD
Valproic Acid—SLC22A5—cardiac atrium—lung cancer	0.000314	0.00575	CbGeAlD
Valproic Acid—HDAC2—Teniposide—Etoposide—lung cancer	0.000303	0.0902	CbGdCrCtD
Valproic Acid—PTGS1—epithelium—lung cancer	0.000297	0.00543	CbGeAlD
Valproic Acid—SLC16A1—lymph node—lung cancer	0.000288	0.00526	CbGeAlD
Valproic Acid—PTGS1—trachea—lung cancer	0.000263	0.0048	CbGeAlD
Valproic Acid—PTGS1—cardiac atrium—lung cancer	0.000247	0.00451	CbGeAlD
Valproic Acid—SLC22A5—lung—lung cancer	0.00024	0.0044	CbGeAlD
Valproic Acid—CYP1A2—lung—lung cancer	0.000218	0.00398	CbGeAlD
Valproic Acid—CYP3A5—lung—lung cancer	0.00021	0.00384	CbGeAlD
Valproic Acid—CYP2B6—lung—lung cancer	0.000209	0.00382	CbGeAlD
Valproic Acid—PTGS1—lung—lung cancer	0.000189	0.00345	CbGeAlD
Valproic Acid—SLC22A5—lymph node—lung cancer	0.000164	0.00301	CbGeAlD
Valproic Acid—PTGS1—lymph node—lung cancer	0.000129	0.00236	CbGeAlD
Valproic Acid—Fatigue—Paclitaxel—lung cancer	4.88e-05	0.000291	CcSEcCtD
Valproic Acid—Haemorrhage—Methotrexate—lung cancer	4.87e-05	0.00029	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—lung cancer	4.87e-05	0.00029	CcSEcCtD
Valproic Acid—Asthenia—Gemcitabine—lung cancer	4.85e-05	0.000289	CcSEcCtD
Valproic Acid—Pain—Paclitaxel—lung cancer	4.84e-05	0.000288	CcSEcCtD
Valproic Acid—Constipation—Paclitaxel—lung cancer	4.84e-05	0.000288	CcSEcCtD
Valproic Acid—Confusional state—Docetaxel—lung cancer	4.84e-05	0.000288	CcSEcCtD
Valproic Acid—Pharyngitis—Methotrexate—lung cancer	4.83e-05	0.000288	CcSEcCtD
Valproic Acid—Urinary tract disorder—Methotrexate—lung cancer	4.81e-05	0.000286	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—lung cancer	4.81e-05	0.000286	CcSEcCtD
Valproic Acid—Anaphylactic shock—Docetaxel—lung cancer	4.8e-05	0.000286	CcSEcCtD
Valproic Acid—Oedema—Docetaxel—lung cancer	4.8e-05	0.000286	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—lung cancer	4.79e-05	0.000286	CcSEcCtD
Valproic Acid—Pruritus—Gemcitabine—lung cancer	4.79e-05	0.000285	CcSEcCtD
Valproic Acid—Urethral disorder—Methotrexate—lung cancer	4.77e-05	0.000284	CcSEcCtD
Valproic Acid—Infection—Docetaxel—lung cancer	4.77e-05	0.000284	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—lung cancer	4.77e-05	0.000284	CcSEcCtD
Valproic Acid—Feeling abnormal—Etoposide—lung cancer	4.76e-05	0.000284	CcSEcCtD
Valproic Acid—Diarrhoea—Irinotecan—lung cancer	4.75e-05	0.000283	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—lung cancer	4.72e-05	0.000281	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Etoposide—lung cancer	4.72e-05	0.000281	CcSEcCtD
Valproic Acid—Nervous system disorder—Docetaxel—lung cancer	4.71e-05	0.00028	CcSEcCtD
Valproic Acid—Thrombocytopenia—Docetaxel—lung cancer	4.7e-05	0.00028	CcSEcCtD
Valproic Acid—Drowsiness—Doxorubicin—lung cancer	4.7e-05	0.00028	CcSEcCtD
Valproic Acid—Visual impairment—Methotrexate—lung cancer	4.69e-05	0.00028	CcSEcCtD
Valproic Acid—Tachycardia—Docetaxel—lung cancer	4.69e-05	0.000279	CcSEcCtD
Valproic Acid—Feeling abnormal—Paclitaxel—lung cancer	4.67e-05	0.000278	CcSEcCtD
Valproic Acid—Skin disorder—Docetaxel—lung cancer	4.66e-05	0.000278	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—lung cancer	4.66e-05	0.000277	CcSEcCtD
Valproic Acid—Hypersensitivity—Cisplatin—lung cancer	4.65e-05	0.000277	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Paclitaxel—lung cancer	4.63e-05	0.000276	CcSEcCtD
Valproic Acid—Diarrhoea—Gemcitabine—lung cancer	4.63e-05	0.000276	CcSEcCtD
Valproic Acid—Erythema multiforme—Methotrexate—lung cancer	4.6e-05	0.000274	CcSEcCtD
Valproic Acid—Dizziness—Irinotecan—lung cancer	4.59e-05	0.000274	CcSEcCtD
Valproic Acid—Urticaria—Etoposide—lung cancer	4.59e-05	0.000273	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—lung cancer	4.58e-05	0.000273	CcSEcCtD
Valproic Acid—Anorexia—Docetaxel—lung cancer	4.58e-05	0.000273	CcSEcCtD
Valproic Acid—Body temperature increased—Etoposide—lung cancer	4.57e-05	0.000272	CcSEcCtD
Valproic Acid—Abdominal pain—Etoposide—lung cancer	4.57e-05	0.000272	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—lung cancer	4.57e-05	0.000272	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—lung cancer	4.57e-05	0.000272	CcSEcCtD
Valproic Acid—Eye disorder—Methotrexate—lung cancer	4.55e-05	0.000271	CcSEcCtD
Valproic Acid—Tinnitus—Methotrexate—lung cancer	4.54e-05	0.00027	CcSEcCtD
Valproic Acid—Asthenia—Cisplatin—lung cancer	4.52e-05	0.000269	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—lung cancer	4.5e-05	0.000268	CcSEcCtD
Valproic Acid—Urticaria—Paclitaxel—lung cancer	4.5e-05	0.000268	CcSEcCtD
Valproic Acid—Hypotension—Docetaxel—lung cancer	4.49e-05	0.000267	CcSEcCtD
Valproic Acid—Abdominal pain—Paclitaxel—lung cancer	4.48e-05	0.000267	CcSEcCtD
Valproic Acid—Body temperature increased—Paclitaxel—lung cancer	4.48e-05	0.000267	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—lung cancer	4.44e-05	0.000265	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—lung cancer	4.43e-05	0.000264	CcSEcCtD
Valproic Acid—Angiopathy—Methotrexate—lung cancer	4.42e-05	0.000263	CcSEcCtD
Valproic Acid—Vomiting—Irinotecan—lung cancer	4.42e-05	0.000263	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—lung cancer	4.41e-05	0.000263	CcSEcCtD
Valproic Acid—Immune system disorder—Methotrexate—lung cancer	4.4e-05	0.000262	CcSEcCtD
Valproic Acid—Mediastinal disorder—Methotrexate—lung cancer	4.39e-05	0.000261	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—lung cancer	4.38e-05	0.000261	CcSEcCtD
Valproic Acid—Rash—Irinotecan—lung cancer	4.38e-05	0.000261	CcSEcCtD
Valproic Acid—Dermatitis—Irinotecan—lung cancer	4.37e-05	0.000261	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Docetaxel—lung cancer	4.37e-05	0.000261	CcSEcCtD
Valproic Acid—Chills—Methotrexate—lung cancer	4.37e-05	0.00026	CcSEcCtD
Valproic Acid—Headache—Irinotecan—lung cancer	4.35e-05	0.000259	CcSEcCtD
Valproic Acid—Insomnia—Docetaxel—lung cancer	4.34e-05	0.000259	CcSEcCtD
Valproic Acid—Diarrhoea—Cisplatin—lung cancer	4.31e-05	0.000257	CcSEcCtD
Valproic Acid—Paraesthesia—Docetaxel—lung cancer	4.31e-05	0.000257	CcSEcCtD
Valproic Acid—Alopecia—Methotrexate—lung cancer	4.3e-05	0.000256	CcSEcCtD
Valproic Acid—Vomiting—Gemcitabine—lung cancer	4.3e-05	0.000256	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—lung cancer	4.29e-05	0.000256	CcSEcCtD
Valproic Acid—Dyspnoea—Docetaxel—lung cancer	4.28e-05	0.000255	CcSEcCtD
Valproic Acid—Somnolence—Docetaxel—lung cancer	4.27e-05	0.000254	CcSEcCtD
Valproic Acid—Mental disorder—Methotrexate—lung cancer	4.27e-05	0.000254	CcSEcCtD
Valproic Acid—Rash—Gemcitabine—lung cancer	4.27e-05	0.000254	CcSEcCtD
Valproic Acid—Dermatitis—Gemcitabine—lung cancer	4.26e-05	0.000254	CcSEcCtD
Valproic Acid—Hypersensitivity—Etoposide—lung cancer	4.26e-05	0.000253	CcSEcCtD
Valproic Acid—Malnutrition—Methotrexate—lung cancer	4.24e-05	0.000253	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—lung cancer	4.24e-05	0.000252	CcSEcCtD
Valproic Acid—Headache—Gemcitabine—lung cancer	4.24e-05	0.000252	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—lung cancer	4.23e-05	0.000252	CcSEcCtD
Valproic Acid—Dyspepsia—Docetaxel—lung cancer	4.23e-05	0.000252	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—lung cancer	4.22e-05	0.000251	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—lung cancer	4.2e-05	0.00025	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—lung cancer	4.19e-05	0.000249	CcSEcCtD
Valproic Acid—Decreased appetite—Docetaxel—lung cancer	4.17e-05	0.000249	CcSEcCtD
Valproic Acid—Hypersensitivity—Paclitaxel—lung cancer	4.17e-05	0.000249	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—lung cancer	4.16e-05	0.000248	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—lung cancer	4.15e-05	0.000247	CcSEcCtD
Valproic Acid—Dysgeusia—Methotrexate—lung cancer	4.15e-05	0.000247	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Docetaxel—lung cancer	4.14e-05	0.000247	CcSEcCtD
Valproic Acid—Asthenia—Etoposide—lung cancer	4.14e-05	0.000247	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—lung cancer	4.14e-05	0.000247	CcSEcCtD
Valproic Acid—Fatigue—Docetaxel—lung cancer	4.14e-05	0.000247	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—lung cancer	4.13e-05	0.000246	CcSEcCtD
Valproic Acid—Nausea—Irinotecan—lung cancer	4.12e-05	0.000246	CcSEcCtD
Valproic Acid—Pain—Docetaxel—lung cancer	4.11e-05	0.000245	CcSEcCtD
Valproic Acid—Constipation—Docetaxel—lung cancer	4.11e-05	0.000245	CcSEcCtD
Valproic Acid—Back pain—Methotrexate—lung cancer	4.1e-05	0.000244	CcSEcCtD
Valproic Acid—Pruritus—Etoposide—lung cancer	4.09e-05	0.000243	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—lung cancer	4.06e-05	0.000242	CcSEcCtD
Valproic Acid—Asthenia—Paclitaxel—lung cancer	4.06e-05	0.000242	CcSEcCtD
Valproic Acid—Nausea—Gemcitabine—lung cancer	4.02e-05	0.000239	CcSEcCtD
Valproic Acid—Vomiting—Cisplatin—lung cancer	4.01e-05	0.000239	CcSEcCtD
Valproic Acid—Pruritus—Paclitaxel—lung cancer	4.01e-05	0.000239	CcSEcCtD
Valproic Acid—Vision blurred—Methotrexate—lung cancer	4e-05	0.000238	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—lung cancer	3.99e-05	0.000237	CcSEcCtD
Valproic Acid—Rash—Cisplatin—lung cancer	3.98e-05	0.000237	CcSEcCtD
Valproic Acid—Dermatitis—Cisplatin—lung cancer	3.97e-05	0.000237	CcSEcCtD
Valproic Acid—Feeling abnormal—Docetaxel—lung cancer	3.96e-05	0.000236	CcSEcCtD
Valproic Acid—Diarrhoea—Etoposide—lung cancer	3.95e-05	0.000235	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—lung cancer	3.94e-05	0.000235	CcSEcCtD
Valproic Acid—Ill-defined disorder—Methotrexate—lung cancer	3.93e-05	0.000234	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—lung cancer	3.93e-05	0.000234	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Docetaxel—lung cancer	3.93e-05	0.000234	CcSEcCtD
Valproic Acid—Anaemia—Methotrexate—lung cancer	3.92e-05	0.000233	CcSEcCtD
Valproic Acid—Diarrhoea—Paclitaxel—lung cancer	3.88e-05	0.000231	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—lung cancer	3.83e-05	0.000228	CcSEcCtD
Valproic Acid—Malaise—Methotrexate—lung cancer	3.82e-05	0.000228	CcSEcCtD
Valproic Acid—Dizziness—Etoposide—lung cancer	3.82e-05	0.000228	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—lung cancer	3.81e-05	0.000227	CcSEcCtD
Valproic Acid—Vertigo—Methotrexate—lung cancer	3.81e-05	0.000227	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—lung cancer	3.8e-05	0.000226	CcSEcCtD
Valproic Acid—Abdominal pain—Docetaxel—lung cancer	3.79e-05	0.000226	CcSEcCtD
Valproic Acid—Body temperature increased—Docetaxel—lung cancer	3.79e-05	0.000226	CcSEcCtD
Valproic Acid—Leukopenia—Methotrexate—lung cancer	3.79e-05	0.000226	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—lung cancer	3.78e-05	0.000225	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—lung cancer	3.77e-05	0.000224	CcSEcCtD
Valproic Acid—Dizziness—Paclitaxel—lung cancer	3.75e-05	0.000223	CcSEcCtD
Valproic Acid—Nausea—Cisplatin—lung cancer	3.75e-05	0.000223	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—lung cancer	3.73e-05	0.000222	CcSEcCtD
Valproic Acid—Cough—Methotrexate—lung cancer	3.7e-05	0.00022	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—lung cancer	3.69e-05	0.00022	CcSEcCtD
Valproic Acid—Vomiting—Etoposide—lung cancer	3.67e-05	0.000219	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—lung cancer	3.67e-05	0.000219	CcSEcCtD
Valproic Acid—Rash—Etoposide—lung cancer	3.64e-05	0.000217	CcSEcCtD
Valproic Acid—Dermatitis—Etoposide—lung cancer	3.64e-05	0.000217	CcSEcCtD
Valproic Acid—Headache—Etoposide—lung cancer	3.62e-05	0.000216	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—lung cancer	3.62e-05	0.000215	CcSEcCtD
Valproic Acid—Arthralgia—Methotrexate—lung cancer	3.61e-05	0.000215	CcSEcCtD
Valproic Acid—Myalgia—Methotrexate—lung cancer	3.61e-05	0.000215	CcSEcCtD
Valproic Acid—Chest pain—Methotrexate—lung cancer	3.61e-05	0.000215	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—lung cancer	3.6e-05	0.000215	CcSEcCtD
Valproic Acid—Vomiting—Paclitaxel—lung cancer	3.6e-05	0.000214	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—lung cancer	3.59e-05	0.000214	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.58e-05	0.000214	CcSEcCtD
Valproic Acid—Rash—Paclitaxel—lung cancer	3.57e-05	0.000213	CcSEcCtD
Valproic Acid—Dermatitis—Paclitaxel—lung cancer	3.57e-05	0.000213	CcSEcCtD
Valproic Acid—Discomfort—Methotrexate—lung cancer	3.57e-05	0.000212	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—lung cancer	3.57e-05	0.000212	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—lung cancer	3.55e-05	0.000212	CcSEcCtD
Valproic Acid—Headache—Paclitaxel—lung cancer	3.55e-05	0.000211	CcSEcCtD
Valproic Acid—Hypersensitivity—Docetaxel—lung cancer	3.54e-05	0.000211	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—lung cancer	3.53e-05	0.00021	CcSEcCtD
Valproic Acid—Confusional state—Methotrexate—lung cancer	3.49e-05	0.000208	CcSEcCtD
Valproic Acid—Anaphylactic shock—Methotrexate—lung cancer	3.46e-05	0.000206	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—lung cancer	3.46e-05	0.000206	CcSEcCtD
Valproic Acid—Asthenia—Docetaxel—lung cancer	3.44e-05	0.000205	CcSEcCtD
Valproic Acid—Infection—Methotrexate—lung cancer	3.44e-05	0.000205	CcSEcCtD
Valproic Acid—Nausea—Etoposide—lung cancer	3.43e-05	0.000204	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—lung cancer	3.41e-05	0.000203	CcSEcCtD
Valproic Acid—Pruritus—Docetaxel—lung cancer	3.4e-05	0.000202	CcSEcCtD
Valproic Acid—Nervous system disorder—Methotrexate—lung cancer	3.39e-05	0.000202	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—lung cancer	3.39e-05	0.000202	CcSEcCtD
Valproic Acid—Thrombocytopenia—Methotrexate—lung cancer	3.39e-05	0.000202	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—lung cancer	3.37e-05	0.000201	CcSEcCtD
Valproic Acid—Nausea—Paclitaxel—lung cancer	3.36e-05	0.0002	CcSEcCtD
Valproic Acid—Skin disorder—Methotrexate—lung cancer	3.36e-05	0.0002	CcSEcCtD
Valproic Acid—Hyperhidrosis—Methotrexate—lung cancer	3.34e-05	0.000199	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—lung cancer	3.31e-05	0.000197	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—lung cancer	3.3e-05	0.000196	CcSEcCtD
Valproic Acid—Anorexia—Methotrexate—lung cancer	3.3e-05	0.000196	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—lung cancer	3.29e-05	0.000196	CcSEcCtD
Valproic Acid—Diarrhoea—Docetaxel—lung cancer	3.28e-05	0.000196	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—lung cancer	3.24e-05	0.000193	CcSEcCtD
Valproic Acid—Hypotension—Methotrexate—lung cancer	3.23e-05	0.000193	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—lung cancer	3.2e-05	0.000191	CcSEcCtD
Valproic Acid—Dizziness—Docetaxel—lung cancer	3.17e-05	0.000189	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—lung cancer	3.17e-05	0.000189	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Methotrexate—lung cancer	3.15e-05	0.000188	CcSEcCtD
Valproic Acid—Insomnia—Methotrexate—lung cancer	3.13e-05	0.000186	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—lung cancer	3.13e-05	0.000186	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—lung cancer	3.13e-05	0.000186	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—lung cancer	3.13e-05	0.000186	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—lung cancer	3.11e-05	0.000186	CcSEcCtD
Valproic Acid—Paraesthesia—Methotrexate—lung cancer	3.11e-05	0.000185	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.1e-05	0.000185	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—lung cancer	3.09e-05	0.000184	CcSEcCtD
Valproic Acid—Dyspnoea—Methotrexate—lung cancer	3.08e-05	0.000184	CcSEcCtD
Valproic Acid—Somnolence—Methotrexate—lung cancer	3.08e-05	0.000183	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—lung cancer	3.06e-05	0.000182	CcSEcCtD
Valproic Acid—Vomiting—Docetaxel—lung cancer	3.05e-05	0.000182	CcSEcCtD
Valproic Acid—Dyspepsia—Methotrexate—lung cancer	3.05e-05	0.000181	CcSEcCtD
Valproic Acid—Rash—Docetaxel—lung cancer	3.03e-05	0.00018	CcSEcCtD
Valproic Acid—Dermatitis—Docetaxel—lung cancer	3.02e-05	0.00018	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—lung cancer	3.02e-05	0.00018	CcSEcCtD
Valproic Acid—Decreased appetite—Methotrexate—lung cancer	3.01e-05	0.000179	CcSEcCtD
Valproic Acid—Headache—Docetaxel—lung cancer	3.01e-05	0.000179	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—lung cancer	3e-05	0.000178	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—lung cancer	3e-05	0.000178	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Methotrexate—lung cancer	2.99e-05	0.000178	CcSEcCtD
Valproic Acid—Fatigue—Methotrexate—lung cancer	2.98e-05	0.000178	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—lung cancer	2.98e-05	0.000177	CcSEcCtD
Valproic Acid—Pain—Methotrexate—lung cancer	2.96e-05	0.000176	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—lung cancer	2.94e-05	0.000175	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—lung cancer	2.93e-05	0.000175	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—lung cancer	2.92e-05	0.000174	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—lung cancer	2.91e-05	0.000173	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—lung cancer	2.9e-05	0.000173	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—lung cancer	2.86e-05	0.00017	CcSEcCtD
Valproic Acid—Nausea—Docetaxel—lung cancer	2.85e-05	0.00017	CcSEcCtD
Valproic Acid—Feeling abnormal—Methotrexate—lung cancer	2.85e-05	0.00017	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methotrexate—lung cancer	2.83e-05	0.000169	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—lung cancer	2.8e-05	0.000167	CcSEcCtD
Valproic Acid—Urticaria—Methotrexate—lung cancer	2.75e-05	0.000164	CcSEcCtD
Valproic Acid—Abdominal pain—Methotrexate—lung cancer	2.74e-05	0.000163	CcSEcCtD
Valproic Acid—Body temperature increased—Methotrexate—lung cancer	2.74e-05	0.000163	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.73e-05	0.000163	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—lung cancer	2.71e-05	0.000161	CcSEcCtD
Valproic Acid—Paraesthesia—Doxorubicin—lung cancer	2.69e-05	0.00016	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—lung cancer	2.67e-05	0.000159	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—lung cancer	2.66e-05	0.000159	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—lung cancer	2.64e-05	0.000157	CcSEcCtD
Valproic Acid—Decreased appetite—Doxorubicin—lung cancer	2.6e-05	0.000155	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—lung cancer	2.59e-05	0.000154	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—lung cancer	2.58e-05	0.000154	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—lung cancer	2.56e-05	0.000153	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—lung cancer	2.56e-05	0.000153	CcSEcCtD
Valproic Acid—Hypersensitivity—Methotrexate—lung cancer	2.55e-05	0.000152	CcSEcCtD
Valproic Acid—Asthenia—Methotrexate—lung cancer	2.48e-05	0.000148	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—lung cancer	2.47e-05	0.000147	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Doxorubicin—lung cancer	2.45e-05	0.000146	CcSEcCtD
Valproic Acid—Pruritus—Methotrexate—lung cancer	2.45e-05	0.000146	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—lung cancer	2.38e-05	0.000142	CcSEcCtD
Valproic Acid—Abdominal pain—Doxorubicin—lung cancer	2.37e-05	0.000141	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—lung cancer	2.37e-05	0.000141	CcSEcCtD
Valproic Acid—Diarrhoea—Methotrexate—lung cancer	2.37e-05	0.000141	CcSEcCtD
Valproic Acid—Dizziness—Methotrexate—lung cancer	2.29e-05	0.000136	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—lung cancer	2.21e-05	0.000131	CcSEcCtD
Valproic Acid—Vomiting—Methotrexate—lung cancer	2.2e-05	0.000131	CcSEcCtD
Valproic Acid—Rash—Methotrexate—lung cancer	2.18e-05	0.00013	CcSEcCtD
Valproic Acid—Dermatitis—Methotrexate—lung cancer	2.18e-05	0.00013	CcSEcCtD
Valproic Acid—Headache—Methotrexate—lung cancer	2.17e-05	0.000129	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—lung cancer	2.15e-05	0.000128	CcSEcCtD
Valproic Acid—Pruritus—Doxorubicin—lung cancer	2.12e-05	0.000126	CcSEcCtD
Valproic Acid—Nausea—Methotrexate—lung cancer	2.06e-05	0.000122	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—lung cancer	2.05e-05	0.000122	CcSEcCtD
Valproic Acid—Dizziness—Doxorubicin—lung cancer	1.98e-05	0.000118	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—lung cancer	1.9e-05	0.000113	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—lung cancer	1.89e-05	0.000113	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—lung cancer	1.89e-05	0.000112	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—lung cancer	1.88e-05	0.000112	CcSEcCtD
Valproic Acid—Nausea—Doxorubicin—lung cancer	1.78e-05	0.000106	CcSEcCtD
Valproic Acid—CYP3A5—Metabolism—TYMS—lung cancer	2.33e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NQO1—lung cancer	2.33e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.32e-06	1.46e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTM1—lung cancer	2.31e-06	1.46e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CG—lung cancer	2.3e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—lung cancer	2.3e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—lung cancer	2.29e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCG2—lung cancer	2.29e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ADCY1—lung cancer	2.29e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—lung cancer	2.29e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—JUN—lung cancer	2.29e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.28e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTA2—lung cancer	2.28e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.26e-06	1.43e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—EP300—lung cancer	2.25e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HPGDS—lung cancer	2.25e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO2—lung cancer	2.25e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP1A1—lung cancer	2.24e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.23e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—lung cancer	2.23e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—lung cancer	2.23e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1A—lung cancer	2.22e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ERCC2—lung cancer	2.22e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—lung cancer	2.21e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.21e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.21e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTA1—lung cancer	2.2e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—EP300—lung cancer	2.19e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP1A1—lung cancer	2.19e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—POMC—lung cancer	2.19e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTT1—lung cancer	2.18e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTP1—lung cancer	2.17e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CG—lung cancer	2.17e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCC3—lung cancer	2.17e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ERCC2—lung cancer	2.17e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CB—lung cancer	2.16e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GCLC—lung cancer	2.16e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP2A6—lung cancer	2.16e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.15e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP2E1—lung cancer	2.15e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—lung cancer	2.14e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CREBBP—lung cancer	2.13e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NQO1—lung cancer	2.12e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CAT—lung cancer	2.12e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EP300—lung cancer	2.11e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.1e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKR1C1—lung cancer	2.1e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—STK11—lung cancer	2.1e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.08e-06	1.31e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—POMC—lung cancer	2.07e-06	1.31e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—lung cancer	2.06e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.06e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ABCB1—lung cancer	2.06e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SRC—lung cancer	2.05e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO1—lung cancer	2.04e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—lung cancer	2.04e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—UGT1A1—lung cancer	2.04e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.04e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TYMS—lung cancer	2.02e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CD—lung cancer	2.02e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CREBBP—lung cancer	2.01e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.01e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—lung cancer	2e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTM1—lung cancer	2e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ALB—lung cancer	1.99e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—lung cancer	1.98e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—lung cancer	1.98e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—lung cancer	1.97e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.97e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNG11—lung cancer	1.97e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—lung cancer	1.96e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTP1—lung cancer	1.94e-06	1.23e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOA1—lung cancer	1.92e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—STK11—lung cancer	1.91e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CD—lung cancer	1.91e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—lung cancer	1.9e-06	1.2e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP1A1—lung cancer	1.89e-06	1.2e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK3—lung cancer	1.89e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CAT—lung cancer	1.89e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALB—lung cancer	1.88e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ERCC2—lung cancer	1.88e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.88e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOA1—lung cancer	1.88e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALDOA—lung cancer	1.87e-06	1.18e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—lung cancer	1.87e-06	1.18e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—lung cancer	1.87e-06	1.18e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—lung cancer	1.84e-06	1.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ABCB1—lung cancer	1.84e-06	1.16e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP2E1—lung cancer	1.83e-06	1.16e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—lung cancer	1.82e-06	1.15e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NCOA3—lung cancer	1.82e-06	1.15e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NQO1—lung cancer	1.81e-06	1.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TYMS—lung cancer	1.8e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—lung cancer	1.8e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.8e-06	1.13e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTM1—lung cancer	1.78e-06	1.13e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—EP300—lung cancer	1.78e-06	1.12e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.78e-06	1.12e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ADCY1—lung cancer	1.77e-06	1.12e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCG2—lung cancer	1.77e-06	1.12e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTP1—lung cancer	1.77e-06	1.12e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CB—lung cancer	1.76e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.76e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CG—lung cancer	1.75e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—lung cancer	1.74e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO2—lung cancer	1.74e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HPGDS—lung cancer	1.74e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.72e-06	1.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CAT—lung cancer	1.72e-06	1.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CG—lung cancer	1.71e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.71e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—lung cancer	1.7e-06	1.07e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP1A1—lung cancer	1.69e-06	1.07e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTT1—lung cancer	1.68e-06	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ERCC2—lung cancer	1.68e-06	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ABCB1—lung cancer	1.67e-06	1.06e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—lung cancer	1.67e-06	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—POMC—lung cancer	1.67e-06	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—lung cancer	1.66e-06	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CB—lung cancer	1.66e-06	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP2A6—lung cancer	1.66e-06	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GCLC—lung cancer	1.66e-06	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—lung cancer	1.65e-06	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TYMS—lung cancer	1.64e-06	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—STK11—lung cancer	1.63e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—POMC—lung cancer	1.63e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTM1—lung cancer	1.63e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOA1—lung cancer	1.62e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CREBBP—lung cancer	1.62e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—lung cancer	1.62e-06	1.02e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CREBBP—lung cancer	1.59e-06	1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO1—lung cancer	1.58e-06	9.97e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—lung cancer	1.56e-06	9.87e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.56e-06	9.83e-06	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—lung cancer	1.56e-06	9.83e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1A1—lung cancer	1.54e-06	9.74e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CD—lung cancer	1.54e-06	9.73e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.53e-06	9.69e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ERCC2—lung cancer	1.53e-06	9.66e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—lung cancer	1.52e-06	9.61e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALB—lung cancer	1.52e-06	9.61e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTP1—lung cancer	1.51e-06	9.55e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—lung cancer	1.51e-06	9.54e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CD—lung cancer	1.51e-06	9.51e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALB—lung cancer	1.49e-06	9.39e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CG—lung cancer	1.48e-06	9.37e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CAT—lung cancer	1.47e-06	9.29e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.46e-06	9.24e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOA1—lung cancer	1.45e-06	9.16e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—EP300—lung cancer	1.45e-06	9.16e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—lung cancer	1.44e-06	9.13e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—lung cancer	1.44e-06	9.08e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCB1—lung cancer	1.43e-06	9.04e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP2E1—lung cancer	1.41e-06	8.94e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—POMC—lung cancer	1.41e-06	8.92e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TYMS—lung cancer	1.41e-06	8.88e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NQO1—lung cancer	1.4e-06	8.84e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTM1—lung cancer	1.39e-06	8.78e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.39e-06	8.77e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—lung cancer	1.38e-06	8.74e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CREBBP—lung cancer	1.38e-06	8.69e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—EP300—lung cancer	1.37e-06	8.66e-06	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—lung cancer	1.36e-06	8.59e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CB—lung cancer	1.34e-06	8.48e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—lung cancer	1.33e-06	8.4e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CG—lung cancer	1.32e-06	8.36e-06	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—lung cancer	1.32e-06	8.36e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOA1—lung cancer	1.32e-06	8.35e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP1A1—lung cancer	1.32e-06	8.32e-06	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—lung cancer	1.32e-06	8.31e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CB—lung cancer	1.31e-06	8.29e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ERCC2—lung cancer	1.31e-06	8.25e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CD—lung cancer	1.3e-06	8.24e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—lung cancer	1.3e-06	8.21e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALB—lung cancer	1.29e-06	8.13e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—lung cancer	1.28e-06	8.06e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.27e-06	8e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—STK11—lung cancer	1.26e-06	7.97e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—POMC—lung cancer	1.26e-06	7.96e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CREBBP—lung cancer	1.23e-06	7.76e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CG—lung cancer	1.21e-06	7.63e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTP1—lung cancer	1.17e-06	7.37e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CD—lung cancer	1.16e-06	7.35e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—lung cancer	1.16e-06	7.33e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—POMC—lung cancer	1.15e-06	7.26e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALB—lung cancer	1.15e-06	7.26e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CB—lung cancer	1.14e-06	7.18e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CAT—lung cancer	1.14e-06	7.17e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—lung cancer	1.13e-06	7.16e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOA1—lung cancer	1.13e-06	7.14e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—lung cancer	1.13e-06	7.11e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CREBBP—lung cancer	1.12e-06	7.07e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—EP300—lung cancer	1.11e-06	6.99e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCB1—lung cancer	1.1e-06	6.98e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TYMS—lung cancer	1.08e-06	6.85e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.08e-06	6.84e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—EP300—lung cancer	1.08e-06	6.83e-06	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—lung cancer	1.08e-06	6.79e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—lung cancer	1.07e-06	6.78e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTM1—lung cancer	1.07e-06	6.77e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CD—lung cancer	1.06e-06	6.7e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALB—lung cancer	1.05e-06	6.62e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CG—lung cancer	1.03e-06	6.52e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1A1—lung cancer	1.02e-06	6.42e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CB—lung cancer	1.01e-06	6.41e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—lung cancer	1.01e-06	6.41e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ERCC2—lung cancer	1.01e-06	6.37e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—lung cancer	1.01e-06	6.35e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—lung cancer	9.82e-07	6.2e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—POMC—lung cancer	9.82e-07	6.2e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CREBBP—lung cancer	9.57e-07	6.04e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—EP300—lung cancer	9.37e-07	5.92e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CB—lung cancer	9.25e-07	5.84e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—lung cancer	9.17e-07	5.79e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CD—lung cancer	9.07e-07	5.73e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALB—lung cancer	8.95e-07	5.66e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—lung cancer	8.77e-07	5.54e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—lung cancer	8.76e-07	5.54e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOA1—lung cancer	8.72e-07	5.51e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—EP300—lung cancer	8.36e-07	5.28e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—lung cancer	8.29e-07	5.24e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—lung cancer	8.19e-07	5.17e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—lung cancer	8e-07	5.05e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—lung cancer	7.99e-07	5.05e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CG—lung cancer	7.96e-07	5.03e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CB—lung cancer	7.91e-07	4.99e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—lung cancer	7.83e-07	4.95e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—EP300—lung cancer	7.62e-07	4.82e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—POMC—lung cancer	7.58e-07	4.79e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CREBBP—lung cancer	7.38e-07	4.66e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CD—lung cancer	7e-07	4.42e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—lung cancer	6.93e-07	4.38e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALB—lung cancer	6.91e-07	4.37e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—lung cancer	6.83e-07	4.32e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—lung cancer	6.69e-07	4.22e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—lung cancer	6.54e-07	4.13e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—EP300—lung cancer	6.51e-07	4.12e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—lung cancer	6.19e-07	3.91e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CB—lung cancer	6.1e-07	3.85e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—lung cancer	6.05e-07	3.82e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—lung cancer	5.66e-07	3.58e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—lung cancer	5.64e-07	3.56e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—lung cancer	5.27e-07	3.33e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—lung cancer	5.05e-07	3.19e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—EP300—lung cancer	5.03e-07	3.18e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—lung cancer	4.82e-07	3.04e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—lung cancer	4.61e-07	2.91e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—lung cancer	3.94e-07	2.49e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—lung cancer	3.72e-07	2.35e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—lung cancer	3.04e-07	1.92e-06	CbGpPWpGaD
